Moving beyond minimization trials in kidney transplantation

Journal of the American Society of Nephrology

Volumn 26, Issue 12, 2015, Pages 2898-2901

  Matas, Arthur J ^a   Gaston, Robert S ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL9 CHEMOKINE; MYCOPHENOLATE MOFETIL; PREDNISONE; TACROLIMUS; CALCINEURIN INHIBITOR; HLA DQ ANTIGEN;

ACUTE GRAFT REJECTION; DRUG SAFETY; EDITORIAL; GRAFT DYSFUNCTION; GRAFT SURVIVAL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME; FEMALE; GRAFT REJECTION; IMMUNOLOGY; KIDNEY; MALE; PATHOLOGY; TREATMENT WITHDRAWAL;

CALCINEURIN INHIBITORS; FEMALE; GRAFT REJECTION; HLA-DQ ANTIGENS; HUMANS; KIDNEY; MALE; TACROLIMUS; WITHHOLDING TREATMENT;

EID: 84958231740     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015030245     Document Type: Editorial

References (24)

1. Starzl TE, Porter KA, Halgrimson CG, Husberg BS, Penn I, Putnam CW: A decade followup in early cases of renal homotransplantation. Ann Surg 180: 606-616, 1974
2. Hricik DE, O'Toole MA, Schulak JA, Herson J: Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: A meta-analysis. J Am Soc Nephrol 4: 1300-1305, 1993
3. Ahsan N, Hricik D, Matas A, Rose S, Tomlanovich S, Wilkinson A, Ewell M, McIntosh M, Stablein D, Hodge E: Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil - a prospective randomized study. Steroid Withdrawal Study Group. Transplantation 68: 1865-1874, 1999
4. VanrenterghemY, Lebranchu Y,Hené R,Oppenheimer F, EkbergH:Doubleblind comparison of twocorticosteroidregimens plusmycophenolatemofetil and cyclosporine for prevention of acute renal allograft rejection. Transplantation 70: 1352-1359, 2000
5. Woodle ES, First MR, Pirsch J, Shihab F, Gaber AO, Van Veldhuisen P, Astellas Corticosteroid Withdrawal Study Group: A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Ann Surg 248: 564-577, 2008
6. Cantarovich D, Rostaing L, Kamar N, Ducloux D, Saint-Hillier Y,Mourad G,Garrique V,Wolf P, Ellero B, Cassuto E, Albano L, Völp A, Soulilou JP, FRANCIA Study Trial Investigators Group: Early corticosteroid avoidance in kidney transplant recipients receiving ATG-F induction: 5-year actual results of a prospective and randomized study. Am J Transplant 14: 2556-2564, 2014
7. Rizzari MD, Suszynski TM, Gillingham KJ, Dunn TB, Ibrahim HN, Payne WD, Chinnakotla S, Finger EB, Sutherland DE, Kandaswamy R,Najarian JS, Pruett TL, Kukla A, Spong R, Matas AJ: Ten-year outcome after rapid discontinuation of prednisone in adult primary kidney transplantation. Clin J Am Soc Nephrol 7: 494-503, 2012
8. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR: The natural history of chronic allograft nephropathy. N Engl JMed 349: 2326-2333, 2003
9. Sharif A, Shabir S, Chand S, Cockwell P, Ball S, Borrows R:Meta-analysis of calcineurin-inhibitor-sparing regimens in kidney transplantation. J Am Soc Nephrol 22: 2107-2118, 2011
10. SalvadoriM, Bertoni E: Is it time to give up with calcineurin inhibitors in kidney transplantation? World J Transplant 3: 7-25, 2013
11. Matas AJ: Chronic progressive calcineurin nephrotoxicity: an overstated concept. Am J Transplant 11: 687-692, 2011
12. Sellarés J, de Freitas DG,MengelM, Reeve J, Einecke G, Sis B, Hidalgo LG, Famulski K, Matas A, Halloran PF: Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 12: 388-399, 2012
13. Wiebe C, Gibson IW, Blydt-Hansen TD, Karpinski M, Ho J, Storsley LJ, Goldberg A, Birk PE, Rush DN, Nickerson PW: Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant 12: 1157-1167, 2012
14. Sprangers B, Kuypers DR, Vanrenterghem Y: Immunosuppression: Does one regimen fit all? Transplantation 92: 251-261, 2011
15. Lo DJ, Kaplan B, Kirk AD: Biomarkers for kidney transplant rejection. Nat Rev Nephrol 10: 215-225, 2014
16. Oetting WS, Schladt DP, Leduc R, Jacobson PA, Guan W, Matas AJ, Israni A: DeKAF Investigators. Validation of single nucleotide polymorphisms associated with acute rejection in kidney transplant recipients using a large multi-center cohort. Transpl Int 24: 1231-1238, 2011
17. Hricik DE, Formica RN, Nickerson P, Rush D, Fairchild RL, Poggio ED, Gibson IW,Wiebe C, TinckamK, Bunnapradist S, Samaniego-PicotaM, Brennan DC, Schröppel B, Gaber O, Armstrong B, Ikle D, Diop H, Bridges ND, Heeger PS: Adverse outcomes of tacrolimus withdrawal in immune-quiescent kidney transplant recipients. J Am Soc Nephrol 26: 3114-3122, 2015
18. Hricik DE, Nickerson P, Formica RN, Poggio ED, Rush D, Newell KA, Goebel J, Gibson IW, Fairchild RL, RiggsM, Spain K, IkleD, BridgesND, Heeger PS, CTOT-01 consortium: Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury. Am J Transplant 13: 2634-2644, 2013
19. Wiebe C, Pochinco D, Blydt-Hansen TD, Ho J, Birk PE, Karpinski M, Goldberg A, Storsley LJ, Gibson IW, Rush DN, Nickerson PW: Class II HLA epitope matching - A strategy tominimize de novo donor-specific antibody development and improve outcomes. Am J Transplant 13: 3114-3122, 2013
20. Hunsicker LG, Bennett LE: Design of trials of methods to reduce late renal allograft loss: the price of success. Kidney Int 52: S120-S123, 1995
21. Matas AJ, Smith JM, Skeans MA, Thompson B, Gustafson SK, Stewart DE, Cherikh WS, Wainright JL, Boyle G, Snyder JJ, Israni AK, Kasiske BL: OPTN/SRTR 2013 Annual Data Report: Kidney. Am J Transplant 15[Suppl 2]: 1-34, 2015
22. Wiebe C,Nevins TE, RobinerWN, ThomasW,Matas AJ,NickersonPW: The synergistic effect of class IIHLAepitope-mismatch and nonadherence on acute rejection and graft survival. Am J Transplant 2015, in press
23. Thornley TB, Strom TB: Firmly tilting the balance of clinical transplant immunity towards tolerance. Am J Transplant 15: 583-584, 2015
24. Leventhal J, Miller J, Abecassis M, Tollerud DJ, Ildstad ST: Evolving approaches of hematopoietic stem cell-based therapies to induce tolerance to organ transplants: The long road to tolerance. Clin Pharmacol Ther 93: 36-45, 2013